Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Medchemcomm. 2014 Aug;5(8):1213–1217. doi: 10.1039/C4MD00127C

Figure 4.

Figure 4

(A) Dose dependent inhibition of pNP-GlcNAc hydrolysis by intact B. subtilis cells in the presence of BI.fgba confirming that the target is a GlcNAcase. (B) Morphological changes to B. subtilis upon exposure to BI.fgba. Control cells (left) were grown in the presence of 1 % DMSO and show the typical rod shaped cells. Cells on the right were treated with 0.8 × MIC (48 μM) BI.fgba and exhibit an elongated phenotype.